Tengion Inc.

(TNGNQ)

By |

Profile

Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.

Contact Information

Website: www.tengion.com
Email: ir@tengion.com
Main Phone: +1 336 722-5855
Address: 3929 Westpoint Boulevard
Address 2: Suite G
State: NC
City / Town: Winston-Salem
Country: US
Postal Code: 27103

Issuer Information

Exchange: OTO
CEO: John L. Miclot
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.

Contact Information

Website: www.tengion.com
Email: ir@tengion.com
Main Phone: +1 336 722-5855
Address: 3929 Westpoint Boulevard
Address 2: Suite G
State: NC
City / Town: Winston-Salem
Country: US
Postal Code: 27103

Issuer Information

Exchange: OTO
CEO: John L. Miclot
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.0004 $ 0. (0.00%)
Last Price 0.0004 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.0004
Last Trade Volume 2 52 Wk Hi 0.01 52 Wk Low 0.01
Market Cap 16,098 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,245,124.00 EPS (TTM) -0.92 PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7.5 7.5 7.5 7.5
Low Target Price Estimate 7.5 7.5 7.5 7.5
Mean Target Price Estimate 7.5 7.5 7.5 7.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 06/20/12 06/20/12 06/20/12 06/20/12
Form Type Form Description Pages Date
SC 13G/A Amendment to the SC 13G filing 5 2017-01-30
SC 13G/A Amendment to the SC 13G filing 13 2016-02-16
SC 13G/A Amendment to the SC 13G filing 7 2016-02-12
SC 13G Statement of beneficial ownership of common stock by certain persons 9 2015-10-02
SC 13G/A Amendment to the SC 13G filing 9 2015-02-18
SC 13G/A Amendment to the SC 13G filing 8 2015-02-17
SC 13G/A Amendment to the SC 13G filing 13 2015-02-17
SC 13G/A Amendment to the SC 13G filing 5 2015-02-13
SC 13G/A Amendment to the SC 13G filing 7 2015-02-13
SC 13D/A Amendment to a SC 13D filing 8 2015-02-11
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1